financetom
Business
financetom
/
Business
/
RXO Completes Acquisition of Coyote Logistics for $1.03 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RXO Completes Acquisition of Coyote Logistics for $1.03 Billion
Sep 16, 2024 12:30 PM

07:40 AM EDT, 09/16/2024 (MT Newswires) -- RXO (RXO) said Monday that it completed its acquisition of Coyote Logistics from UPS for $1.03 billion, making it the third-largest brokered transportation provider in North America.

With this acquisition, the company said it now offers increased network density and additional power lanes for customers, including access to more customers with opportunities to decrease deadhead miles for carriers.

Price: 25.72, Change: +0.02, Percent Change: +0.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Koppers Keeps Quarterly Dividend at $0.07 a Share, Payable Dec. 16 to Shareholders of Record Nov. 29
--Koppers Keeps Quarterly Dividend at $0.07 a Share, Payable Dec. 16 to Shareholders of Record Nov. 29
Nov 9, 2024
11:33 AM EST, 11/07/2024 (MT Newswires) -- Price: 38.22, Change: -0.76, Percent Change: -1.95 ...
Archer Aviation Strikes Air Taxi Deal in Japan, Shares Rise
Archer Aviation Strikes Air Taxi Deal in Japan, Shares Rise
Nov 9, 2024
11:31 AM EST, 11/07/2024 (MT Newswires) -- Archer Aviation ( ACHR ) and Soracle, a joint venture by Japan Airlines and Sumitomo, agreed to launch advanced air mobility services in Japan using Archer's Midnight aircraft, Archer said Thursday. Soracle aims to order up to 100 aircraft, valued at approximately $500 million, and establish urban air routes in cities like Tokyo...
Mustang Bio Gets FDA Orphan Drug Designation for MB-108 in Malignant Glioma Treatment
Mustang Bio Gets FDA Orphan Drug Designation for MB-108 in Malignant Glioma Treatment
Nov 9, 2024
11:34 AM EST, 11/07/2024 (MT Newswires) -- Mustang Bio ( MBIO ) said Thursday that MB-108, an oncolytic virus currently undergoing phase 1 clinical trial for malignant glioma treatment, has been granted orphan drug designation by the US Food and Drug Administration. The designation provides MB-108 seven years of market exclusivity in the US for the treatment. Mustang also said...
Canada Goose Beats Q2 Estimates, Company Warns Of 'Increased Pressure' On Luxury Consumer Spending
Canada Goose Beats Q2 Estimates, Company Warns Of 'Increased Pressure' On Luxury Consumer Spending
Nov 9, 2024
Canada Goose Holdings Inc. ( GOOS ) reported its second-quarter fiscal 2025 financial results before the market opened on Thursday. Here’s what you need to know. What To Know: Canada Goose reported second-quarter adjusted earnings per share of 5 cents, which may not compare to estimates for a loss of 4 cents. The company reported revenue of $267.8 million, beating...
Copyright 2023-2025 - www.financetom.com All Rights Reserved